Rockwell Medical (RMTI) Cash from Operations (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cash from Operations came in at 200000.0 in Q1 2026, up 94.26% YoY from 102952.47 in Q1 2025, and down 108.89% on a QoQ basis from 2250000.0 in Q4 2025.
Rockwell Medical (RMTI) Cash from Operations (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Cash from Operations data on file, last reported at 200000.0 in Q1 2026.
- Quarterly Cash from Operations rose 94.26% year-over-year to 200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2587000.0 (down 16.41% YoY) and the FY2025 annual result came in at 700000.0, down 116.66% from the prior year.
- Cash from Operations retreated to 200000.0 in Q1 2026, from 2250000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4275000.0 in Q3 2024 to a low of 9811000.0 in Q1 2022.
- A 5-year average of 1355235.29 and a median of 1102000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 240.56% — and 2024, when it soared 2111.63%.
- Tracing RMTI's Cash from Operations over 5 years: stood at 112000.0 in 2022, then jumped by 61.61% to 43000.0 in 2023, then soared by 2111.63% to 865000.0 in 2024, then soared by 160.12% to 2250000.0 in 2025, then plunged by 108.89% to 200000.0 in 2026.
- The last three Cash from Operations figures came in at 200000.0 (Q1 2026), 2250000.0 (Q4 2025), and 1350000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Mn |
| Jun 30, 2026 | 2.11 Mn |
| Mar 31, 2026 | -200,000.00 |
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2025 | 2.25 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | -3.49 Mn |
| Mar 31, 2025 | -3.49 Mn |
| Dec 31, 2024 | 865,000.00 |
| Dec 31, 2024 | 865,000.00 |
| Sep 30, 2024 | 4.28 Mn |
| Sep 30, 2024 | 4.28 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Mar 31, 2024 | -2.38 Mn |